Hospitals will see a surge of people with AIDS-related conditions that we should no longer see in this age of effective ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Exclusive: World Health Organisation says shortage of most commonly used Aids drug caused by withdrawal of US foreign aid ...

Summer is creeping closer, and for Gilead Sciences that only means one thing: the much-anticipated launch of long-acting HIV ...

IN a sunlit shack on the outskirts of Lesotho's capital Maseru, 34-year-old Lieketseng Lucia Tjatji sits under a black cloth ...

If the human immunodeficiency virus is less well suppressed thanks to President Trump’s cuts to USAID, it risks finding more ...

Nigeria is set to begin local production of rapid diagnostic test kits for HIV and malaria in May 2025. This move is expected ...

A Delray Beach man pleaded guilty to conspiracy to commit wire fraud for his role in a national scheme to distribute ...

Mr Trump’s deadline passed on 20 April, with billions of dollars still in limbo. Programmes supporting refugees and treating ...

The National Institutes of Health’s sweeping cuts of grants that fund scientific research are inflicting pain almost ...

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...